Peer Review History
| Original SubmissionJune 19, 2024 |
|---|
|
PONE-D-24-21799Ten-year trends in clinical characteristics and outcome of children hospitalized with severe wasting or nutritional oedema in Malawi (2011-2021): Declining admissions but worsened clinical profilesPLOS ONE Dear Dr. Bourdon, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 06 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Nigusie Selomon Tibebu, MSc Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for uploading your study's underlying data set. Unfortunately, the repository you have noted in your Data Availability statement does not qualify as an acceptable data repository according to PLOS's standards. At this time, please upload the minimal data set necessary to replicate your study's findings to a stable, public repository (such as figshare or Dryad) and provide us with the relevant URLs, DOIs, or accession numbers that may be used to access these data. For a list of recommended repositories and additional information on PLOS standards for data deposition, please see https://journals.plos.org/plosone/s/recommended-repositories. Additional Editor Comments (if provided): [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Re: Ten-year trends in clinical characteristics and outcome of children hospitalized with severe wasting or nutritional oedema in Malawi (2011-2021): Declining admissions but worsened clinical profiles Overall comments There should be a flow chart illustrating patients recruited/enrolment as appropriate Abstract “ Results-line 45 mentioned anthropometry-indicate which parameters you assessed. Line 47 “HIV testing increased but detection remained at 11%.” Is this annually or overall? Clarify Introduction Methods “Medical files were accessed from 8th of June 2020, to 20th of May, 2022” Is this for retrieval of the files? “Files were stored by date of admission, thus, starting from a randomly selected file, every third record was marked for inclusion” please provide ref/any justification for your decision. “Research staff” how many? “demographics (i.e., age, sex, breastfeeding in children < 12 months)” Breastfeeding is not demographics and can it described what you meant breastfeeding less than 12? Still breasting/EBM “‘Access’ (broad-spectrum with a lower risk of resistance) and ‘Watch’ (broad-spectrum with higher risk of selection for bacterial resistance)” Provide examples of these antibiotics from cases. “Implausible anthropometric values of WHZ, HAZ and WAZ were filtered if exceeded +4 or fell below -10 z-scores” how many ? provide the n Results “From 2011 to 2021, Moyo NRU had 4494 admissions, of which 1498 (33%) were randomly selected for inclusion in this retrospective analysis” A bit difficult to understand while the number sampled was not more than this considering the high number of missing variables and incomplete data? Kindly provide rationale for this? Table 1; Insert exact number of available anthropometry rather indicating missing [MUAC, WHZ, WAZ, HAZ], What the access and watch group of antibiotics with examples. “Missingness in anthropometry was undocumented in approximately 40% of health records” this is the greatest limitation of this study and is missing the study limitation, kindly provide exact number that are using. “This decline coincided with an increase in unreported vaccination status of patients” I can not locate this in the results? (i.e. 346 mortality cases out of 1498 children)-This appear incorrect since close to 40% of children did not have anthropometry for proper classification/inclusion/exclusion Table 2-can you clarify the models, model 2 did not include anthropometry??? Discussion “However, there was a significant 40% reduction in the prevalence of nutritional edema” insert n before the percent ? “To the best of our knowledge, this is the first study to cover a 10-year period and highlight changing trends in clinical presentation” This statement should be re-casted, this data has close to half missing with no details of what is missing in the anthropometry “We were unable to capture laboratory or radiological findings or include specific chronic conditions associated with malnutrition like tuberculosis due to low recorded prevalence” How low is this? This should have been reported, it is an important co-morbidity that may influence outcomes Figures 1 to 4 are poor qualities and hard to read, kindly revise to enhance readability S1 Table: The age and sex has non-linear trend, what inform the choice to report non-linear vs linear trend S2 Table: Again non-linear trend was not reported for oedema grade 2 and 3, even if it is not significant, this should be reported for consistency and if it is not done, a footnote should be added indicating why it was not done. S3 Table; Same comments as S2 Table: Non-linear trend not reported for some variables? S7 Table: Same comments S8 Table: ? Non-linear trends? Also, the number of some variables are small? 26 for a whole year? Reviewer #2: Methods Handling of Missing Data: While you mention evaluating trends in missing values and also mention missingness as a contributing limitation towards your choice of methodology (lines 214-215), It is important to detail how missing data were handled in the analysis (e.g., complete case analysis, imputation methods). It is not clear if you only included single entry of each child as a criterion or if it is possible that in the 10 year period a single child could have been admitted several times. If this is the case, it is not clear as to how you dealt with the repeated measures within subjects: If the same children appear multiple times in the dataset, you should include random effects for the child to account for intra-child correlation. This introduces non-independence of the observations. If this is indeed the case, then perhaps mixed effects GAMs would be appropriate. Discussion The synthesis of the evidence presented in the statement could be considered misleading. This sentence should be improved to avoid misinterpretation. line 258-259 "This aligns with our clinical experience, which suggests that while fewer children are admitted to the Moyo NRU,(28) they present with a higher disease intensity." Is this not expected?? This is a tertiary (referral centre) where referrals are made based on disease intensity I presume. Therefore it is inherently predisposed to receiving more severe cases based on criteria. If fewer children are being admitted, the proportion of severe cases might naturally appear higher because only the most severe cases are referred. line 293 "Over the decade, readmissions increased which could be indicative of the persistent vulnerability of these children after discharge and may also relate to the shortened hospital stay observed." I note that readmissions are mentioned here bringing back to how intra-child correlations were addressed. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Ten-year trends in clinical characteristics and outcome of children hospitalized with severe wasting or nutritional edema in Malawi (2011-2021): Declining admissions but worsened clinical profiles PONE-D-24-21799R1 Dear Dr. Celine Bourdon, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Nigusie Selomon Tibebu, MSc Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-21799R1 PLOS ONE Dear Dr. Bourdon, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Assistant Professor Nigusie Selomon Tibebu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .